UNSPSC 51273101: Alfaxalone

This classification denotes an anesthetic agent with the molecular formula C21H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BD07M97B2A, chemically known as 5-alpha-pregnane-11,20-dione, 3-alpha-hydroxy- but generally known as alfaxalone, which bears US NIH Compound Identifier 104845. European Medicines Agency schedules Alfaxalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05316MIG.

UNSPSC 51273101 Alfaxalone is a Commodity code that nominally names a single anesthetic agent, but recent state and local procurement activity under this code does not reflect focused buying of alfaxalone itself. Instead, the code appears in opportunities for broader pharmaceutical and drug-management procurement — including naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals with over-the-counter products. The mismatch between the code's name and actual solicitation scope suggests either misclassification by issuing bodies or a need to verify the code assignment before pursuing opportunities tagged under 51273101. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local government facilities across multiple states including Oregon).

Recent activity spans Florida, Texas, and Minnesota. The most concrete recent opportunity is Seminole County's IFB 60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: date discrepancy in source materials). The Texas HHS Commission issued RFI HHS0017013 on April 3, 2026, exploring vendor capacity for direct-to-manufacturer prescription programs as a market-intelligence exercise ahead of formal procurement. The Minnesota Multistate Cooperative Purchasing Alliance released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026 and contract effectiveness July 1, 2026. Given the disconnect between the code's specific name and the pharmaceuticals actually being procured, verify code assignment with issuing bodies before allocating pursuit resources.